nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—PTGS1—kidney cancer	0.432	0.636	CbGaD
Tolmetin—PTGS2—kidney cancer	0.247	0.364	CbGaD
Tolmetin—Zolpidem—PTGS1—kidney cancer	0.000907	0.125	CrCbGaD
Tolmetin—Ketorolac—PTGS1—kidney cancer	0.000843	0.116	CrCbGaD
Tolmetin—Bromfenac—PTGS1—kidney cancer	0.000808	0.112	CrCbGaD
Tolmetin—Lumiracoxib—PTGS1—kidney cancer	0.000687	0.0949	CrCbGaD
Tolmetin—Fenbufen—PTGS1—kidney cancer	0.000625	0.0864	CrCbGaD
Tolmetin—Stomatitis—Dactinomycin—kidney cancer	0.0006	0.00347	CcSEcCtD
Tolmetin—Flatulence—Everolimus—kidney cancer	0.0006	0.00346	CcSEcCtD
Tolmetin—Visual disturbance—Paclitaxel—kidney cancer	0.000598	0.00346	CcSEcCtD
Tolmetin—Somnolence—Temsirolimus—kidney cancer	0.000594	0.00343	CcSEcCtD
Tolmetin—Hepatitis—Sunitinib—kidney cancer	0.000584	0.00337	CcSEcCtD
Tolmetin—Flatulence—Erlotinib—kidney cancer	0.000579	0.00334	CcSEcCtD
Tolmetin—Dysuria—Vincristine—kidney cancer	0.000577	0.00333	CcSEcCtD
Tolmetin—Agranulocytosis—Dactinomycin—kidney cancer	0.000575	0.00332	CcSEcCtD
Tolmetin—Erythema multiforme—Sorafenib—kidney cancer	0.000574	0.00331	CcSEcCtD
Tolmetin—Constipation—Temsirolimus—kidney cancer	0.000571	0.0033	CcSEcCtD
Tolmetin—Tinnitus—Sorafenib—kidney cancer	0.000566	0.00327	CcSEcCtD
Tolmetin—Somnolence—Pazopanib—kidney cancer	0.000559	0.00323	CcSEcCtD
Tolmetin—Weight decreased—Vincristine—kidney cancer	0.000558	0.00322	CcSEcCtD
Tolmetin—Dyspepsia—Pazopanib—kidney cancer	0.000554	0.0032	CcSEcCtD
Tolmetin—Hepatitis—Dactinomycin—kidney cancer	0.000553	0.00319	CcSEcCtD
Tolmetin—Erythema multiforme—Sunitinib—kidney cancer	0.000552	0.00319	CcSEcCtD
Tolmetin—Gastrointestinal pain—Temsirolimus—kidney cancer	0.000546	0.00315	CcSEcCtD
Tolmetin—Stomatitis—Vincristine—kidney cancer	0.000536	0.0031	CcSEcCtD
Tolmetin—Body temperature increased—Temsirolimus—kidney cancer	0.000528	0.00305	CcSEcCtD
Tolmetin—Abdominal pain—Temsirolimus—kidney cancer	0.000528	0.00305	CcSEcCtD
Tolmetin—Erythema multiforme—Dactinomycin—kidney cancer	0.000523	0.00302	CcSEcCtD
Tolmetin—Suprofen—PTGS1—kidney cancer	0.000521	0.0719	CrCbGaD
Tolmetin—Vascular purpura—Capecitabine—kidney cancer	0.00052	0.003	CcSEcCtD
Tolmetin—Chest pain—Everolimus—kidney cancer	0.000518	0.00299	CcSEcCtD
Tolmetin—Haemolytic anaemia—Capecitabine—kidney cancer	0.000516	0.00298	CcSEcCtD
Tolmetin—Gastrointestinal pain—Pazopanib—kidney cancer	0.000514	0.00297	CcSEcCtD
Tolmetin—Renal failure—Gemcitabine—kidney cancer	0.000513	0.00296	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.000511	0.00295	CcSEcCtD
Tolmetin—Stomatitis—Gemcitabine—kidney cancer	0.000509	0.00294	CcSEcCtD
Tolmetin—Flatulence—Sunitinib—kidney cancer	0.000501	0.00289	CcSEcCtD
Tolmetin—Chest pain—Erlotinib—kidney cancer	0.0005	0.00289	CcSEcCtD
Tolmetin—Haematuria—Gemcitabine—kidney cancer	0.000498	0.00287	CcSEcCtD
Tolmetin—Abdominal pain—Pazopanib—kidney cancer	0.000497	0.00287	CcSEcCtD
Tolmetin—Oedema—Everolimus—kidney cancer	0.000497	0.00287	CcSEcCtD
Tolmetin—Thrombocytopenia—Vinblastine—kidney cancer	0.000488	0.00282	CcSEcCtD
Tolmetin—Agranulocytosis—Gemcitabine—kidney cancer	0.000487	0.00281	CcSEcCtD
Tolmetin—Thrombocytopenia—Everolimus—kidney cancer	0.000486	0.00281	CcSEcCtD
Tolmetin—Purpura—Capecitabine—kidney cancer	0.000483	0.00279	CcSEcCtD
Tolmetin—Ketorolac—PTGS2—kidney cancer	0.000482	0.0666	CrCbGaD
Tolmetin—Oedema—Erlotinib—kidney cancer	0.000479	0.00277	CcSEcCtD
Tolmetin—Asthenia—Temsirolimus—kidney cancer	0.000479	0.00277	CcSEcCtD
Tolmetin—Thrombocytopenia—Erlotinib—kidney cancer	0.000469	0.00271	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.000465	0.00269	CcSEcCtD
Tolmetin—Bromfenac—PTGS2—kidney cancer	0.000462	0.0638	CrCbGaD
Tolmetin—Dysuria—Paclitaxel—kidney cancer	0.000458	0.00265	CcSEcCtD
Tolmetin—Diarrhoea—Temsirolimus—kidney cancer	0.000457	0.00264	CcSEcCtD
Tolmetin—Asthenia—Pazopanib—kidney cancer	0.000451	0.00261	CcSEcCtD
Tolmetin—Glossitis—Doxorubicin—kidney cancer	0.000448	0.00259	CcSEcCtD
Tolmetin—Weight increased—Paclitaxel—kidney cancer	0.000446	0.00258	CcSEcCtD
Tolmetin—Weight decreased—Paclitaxel—kidney cancer	0.000443	0.00256	CcSEcCtD
Tolmetin—Erythema multiforme—Gemcitabine—kidney cancer	0.000443	0.00256	CcSEcCtD
Tolmetin—Somnolence—Everolimus—kidney cancer	0.000442	0.00255	CcSEcCtD
Tolmetin—Dizziness—Temsirolimus—kidney cancer	0.000442	0.00255	CcSEcCtD
Tolmetin—Dyspepsia—Everolimus—kidney cancer	0.000437	0.00253	CcSEcCtD
Tolmetin—Chest pain—Sunitinib—kidney cancer	0.000433	0.0025	CcSEcCtD
Tolmetin—Anaphylactic shock—Sorafenib—kidney cancer	0.000431	0.00249	CcSEcCtD
Tolmetin—Diarrhoea—Pazopanib—kidney cancer	0.00043	0.00249	CcSEcCtD
Tolmetin—Renal failure—Paclitaxel—kidney cancer	0.00043	0.00248	CcSEcCtD
Tolmetin—Constipation—Vinblastine—kidney cancer	0.000426	0.00246	CcSEcCtD
Tolmetin—Stomatitis—Paclitaxel—kidney cancer	0.000426	0.00246	CcSEcCtD
Tolmetin—Urinary tract infection—Paclitaxel—kidney cancer	0.000425	0.00245	CcSEcCtD
Tolmetin—Constipation—Everolimus—kidney cancer	0.000425	0.00245	CcSEcCtD
Tolmetin—Vomiting—Temsirolimus—kidney cancer	0.000425	0.00245	CcSEcCtD
Tolmetin—Thrombocytopenia—Sorafenib—kidney cancer	0.000422	0.00244	CcSEcCtD
Tolmetin—Dyspepsia—Erlotinib—kidney cancer	0.000422	0.00244	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.000419	0.00242	CcSEcCtD
Tolmetin—Headache—Temsirolimus—kidney cancer	0.000418	0.00242	CcSEcCtD
Tolmetin—Haematuria—Paclitaxel—kidney cancer	0.000417	0.00241	CcSEcCtD
Tolmetin—Dizziness—Pazopanib—kidney cancer	0.000416	0.0024	CcSEcCtD
Tolmetin—Oedema—Sunitinib—kidney cancer	0.000415	0.0024	CcSEcCtD
Tolmetin—Epistaxis—Paclitaxel—kidney cancer	0.000412	0.00238	CcSEcCtD
Tolmetin—Gastritis—Capecitabine—kidney cancer	0.000412	0.00238	CcSEcCtD
Tolmetin—Constipation—Erlotinib—kidney cancer	0.00041	0.00237	CcSEcCtD
Tolmetin—Gastrointestinal pain—Vinblastine—kidney cancer	0.000408	0.00235	CcSEcCtD
Tolmetin—Thrombocytopenia—Sunitinib—kidney cancer	0.000406	0.00235	CcSEcCtD
Tolmetin—Gastrointestinal pain—Everolimus—kidney cancer	0.000406	0.00235	CcSEcCtD
Tolmetin—Vomiting—Pazopanib—kidney cancer	0.0004	0.00231	CcSEcCtD
Tolmetin—Nausea—Temsirolimus—kidney cancer	0.000397	0.00229	CcSEcCtD
Tolmetin—Abdominal pain—Vinblastine—kidney cancer	0.000394	0.00228	CcSEcCtD
Tolmetin—Headache—Pazopanib—kidney cancer	0.000394	0.00228	CcSEcCtD
Tolmetin—Lumiracoxib—PTGS2—kidney cancer	0.000393	0.0543	CrCbGaD
Tolmetin—Oedema—Dactinomycin—kidney cancer	0.000393	0.00227	CcSEcCtD
Tolmetin—Abdominal pain—Everolimus—kidney cancer	0.000393	0.00227	CcSEcCtD
Tolmetin—Body temperature increased—Everolimus—kidney cancer	0.000393	0.00227	CcSEcCtD
Tolmetin—Gastrointestinal pain—Erlotinib—kidney cancer	0.000392	0.00226	CcSEcCtD
Tolmetin—Blood urea increased—Doxorubicin—kidney cancer	0.00039	0.00225	CcSEcCtD
Tolmetin—Abdominal discomfort—Capecitabine—kidney cancer	0.000386	0.00223	CcSEcCtD
Tolmetin—Thrombocytopenia—Dactinomycin—kidney cancer	0.000385	0.00222	CcSEcCtD
Tolmetin—Dyspepsia—Sorafenib—kidney cancer	0.00038	0.00219	CcSEcCtD
Tolmetin—Body temperature increased—Erlotinib—kidney cancer	0.000379	0.00219	CcSEcCtD
Tolmetin—Abdominal pain—Erlotinib—kidney cancer	0.000379	0.00219	CcSEcCtD
Tolmetin—Visual impairment—Paclitaxel—kidney cancer	0.000378	0.00218	CcSEcCtD
Tolmetin—Dysuria—Capecitabine—kidney cancer	0.000376	0.00217	CcSEcCtD
Tolmetin—Nausea—Pazopanib—kidney cancer	0.000374	0.00216	CcSEcCtD
Tolmetin—Erythema multiforme—Paclitaxel—kidney cancer	0.000371	0.00214	CcSEcCtD
Tolmetin—Constipation—Sorafenib—kidney cancer	0.000369	0.00213	CcSEcCtD
Tolmetin—Weight increased—Capecitabine—kidney cancer	0.000366	0.00211	CcSEcCtD
Tolmetin—Tinnitus—Paclitaxel—kidney cancer	0.000366	0.00211	CcSEcCtD
Tolmetin—Dyspepsia—Sunitinib—kidney cancer	0.000365	0.00211	CcSEcCtD
Tolmetin—Weight decreased—Capecitabine—kidney cancer	0.000364	0.0021	CcSEcCtD
Tolmetin—Asthenia—Vinblastine—kidney cancer	0.000358	0.00207	CcSEcCtD
Tolmetin—Fenbufen—PTGS2—kidney cancer	0.000357	0.0494	CrCbGaD
Tolmetin—Asthenia—Everolimus—kidney cancer	0.000356	0.00206	CcSEcCtD
Tolmetin—Constipation—Sunitinib—kidney cancer	0.000355	0.00205	CcSEcCtD
Tolmetin—Gastrointestinal pain—Sorafenib—kidney cancer	0.000353	0.00204	CcSEcCtD
Tolmetin—Renal failure—Capecitabine—kidney cancer	0.000353	0.00204	CcSEcCtD
Tolmetin—Lymphadenopathy—Doxorubicin—kidney cancer	0.000352	0.00203	CcSEcCtD
Tolmetin—Anaphylactic shock—Vincristine—kidney cancer	0.000351	0.00203	CcSEcCtD
Tolmetin—Oedema—Vincristine—kidney cancer	0.000351	0.00203	CcSEcCtD
Tolmetin—Stomatitis—Capecitabine—kidney cancer	0.00035	0.00202	CcSEcCtD
Tolmetin—Urinary tract infection—Capecitabine—kidney cancer	0.000349	0.00201	CcSEcCtD
Tolmetin—Chest pain—Gemcitabine—kidney cancer	0.000347	0.00201	CcSEcCtD
Tolmetin—Asthenia—Erlotinib—kidney cancer	0.000344	0.00199	CcSEcCtD
Tolmetin—Thrombocytopenia—Vincristine—kidney cancer	0.000344	0.00198	CcSEcCtD
Tolmetin—Urticaria—Sorafenib—kidney cancer	0.000343	0.00198	CcSEcCtD
Tolmetin—Haematuria—Capecitabine—kidney cancer	0.000342	0.00197	CcSEcCtD
Tolmetin—Diarrhoea—Vinblastine—kidney cancer	0.000341	0.00197	CcSEcCtD
Tolmetin—Body temperature increased—Sorafenib—kidney cancer	0.000341	0.00197	CcSEcCtD
Tolmetin—Abdominal pain—Sorafenib—kidney cancer	0.000341	0.00197	CcSEcCtD
Tolmetin—Diarrhoea—Everolimus—kidney cancer	0.00034	0.00196	CcSEcCtD
Tolmetin—Gastrointestinal pain—Sunitinib—kidney cancer	0.000339	0.00196	CcSEcCtD
Tolmetin—Epistaxis—Capecitabine—kidney cancer	0.000338	0.00195	CcSEcCtD
Tolmetin—Flatulence—Paclitaxel—kidney cancer	0.000337	0.00194	CcSEcCtD
Tolmetin—Vascular purpura—Doxorubicin—kidney cancer	0.000335	0.00194	CcSEcCtD
Tolmetin—Agranulocytosis—Capecitabine—kidney cancer	0.000335	0.00193	CcSEcCtD
Tolmetin—Anaphylactic shock—Gemcitabine—kidney cancer	0.000333	0.00192	CcSEcCtD
Tolmetin—Oedema—Gemcitabine—kidney cancer	0.000333	0.00192	CcSEcCtD
Tolmetin—Indomethacin—PTGS1—kidney cancer	0.000331	0.0458	CrCbGaD
Tolmetin—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000331	0.00191	CcSEcCtD
Tolmetin—Dizziness—Vinblastine—kidney cancer	0.00033	0.0019	CcSEcCtD
Tolmetin—Dizziness—Everolimus—kidney cancer	0.000328	0.0019	CcSEcCtD
Tolmetin—Abdominal pain—Sunitinib—kidney cancer	0.000328	0.00189	CcSEcCtD
Tolmetin—Body temperature increased—Sunitinib—kidney cancer	0.000328	0.00189	CcSEcCtD
Tolmetin—Diarrhoea—Erlotinib—kidney cancer	0.000328	0.00189	CcSEcCtD
Tolmetin—Thrombocytopenia—Gemcitabine—kidney cancer	0.000326	0.00188	CcSEcCtD
Tolmetin—Hepatitis—Capecitabine—kidney cancer	0.000322	0.00186	CcSEcCtD
Tolmetin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000321	0.00185	CcSEcCtD
Tolmetin—Vomiting—Vinblastine—kidney cancer	0.000317	0.00183	CcSEcCtD
Tolmetin—Dizziness—Erlotinib—kidney cancer	0.000317	0.00183	CcSEcCtD
Tolmetin—Vomiting—Everolimus—kidney cancer	0.000316	0.00182	CcSEcCtD
Tolmetin—Headache—Vinblastine—kidney cancer	0.000312	0.0018	CcSEcCtD
Tolmetin—Purpura—Doxorubicin—kidney cancer	0.000311	0.0018	CcSEcCtD
Tolmetin—Headache—Everolimus—kidney cancer	0.000311	0.0018	CcSEcCtD
Tolmetin—Abdominal pain—Dactinomycin—kidney cancer	0.000311	0.00179	CcSEcCtD
Tolmetin—Body temperature increased—Dactinomycin—kidney cancer	0.000311	0.00179	CcSEcCtD
Tolmetin—Visual impairment—Capecitabine—kidney cancer	0.00031	0.00179	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.00031	0.00179	CcSEcCtD
Tolmetin—Asthenia—Sorafenib—kidney cancer	0.000309	0.00179	CcSEcCtD
Tolmetin—Vomiting—Erlotinib—kidney cancer	0.000305	0.00176	CcSEcCtD
Tolmetin—Erythema multiforme—Capecitabine—kidney cancer	0.000304	0.00176	CcSEcCtD
Tolmetin—Headache—Erlotinib—kidney cancer	0.0003	0.00173	CcSEcCtD
Tolmetin—Tinnitus—Capecitabine—kidney cancer	0.0003	0.00173	CcSEcCtD
Tolmetin—Constipation—Vincristine—kidney cancer	0.0003	0.00173	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.0003	0.00173	CcSEcCtD
Tolmetin—Suprofen—PTGS2—kidney cancer	0.000298	0.0411	CrCbGaD
Tolmetin—Asthenia—Sunitinib—kidney cancer	0.000298	0.00172	CcSEcCtD
Tolmetin—Nausea—Vinblastine—kidney cancer	0.000296	0.00171	CcSEcCtD
Tolmetin—Somnolence—Gemcitabine—kidney cancer	0.000296	0.00171	CcSEcCtD
Tolmetin—Nausea—Everolimus—kidney cancer	0.000295	0.0017	CcSEcCtD
Tolmetin—Diarrhoea—Sorafenib—kidney cancer	0.000295	0.0017	CcSEcCtD
Tolmetin—Chest pain—Paclitaxel—kidney cancer	0.000291	0.00168	CcSEcCtD
Tolmetin—Gastrointestinal pain—Vincristine—kidney cancer	0.000287	0.00166	CcSEcCtD
Tolmetin—Dizziness—Sorafenib—kidney cancer	0.000285	0.00165	CcSEcCtD
Tolmetin—Constipation—Gemcitabine—kidney cancer	0.000285	0.00164	CcSEcCtD
Tolmetin—Nausea—Erlotinib—kidney cancer	0.000285	0.00164	CcSEcCtD
Tolmetin—Diarrhoea—Sunitinib—kidney cancer	0.000284	0.00164	CcSEcCtD
Tolmetin—Asthenia—Dactinomycin—kidney cancer	0.000282	0.00163	CcSEcCtD
Tolmetin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000279	0.00161	CcSEcCtD
Tolmetin—Oedema—Paclitaxel—kidney cancer	0.000279	0.00161	CcSEcCtD
Tolmetin—Abdominal pain—Vincristine—kidney cancer	0.000277	0.0016	CcSEcCtD
Tolmetin—Body temperature increased—Vincristine—kidney cancer	0.000277	0.0016	CcSEcCtD
Tolmetin—Flatulence—Capecitabine—kidney cancer	0.000276	0.00159	CcSEcCtD
Tolmetin—Dizziness—Sunitinib—kidney cancer	0.000274	0.00158	CcSEcCtD
Tolmetin—Vomiting—Sorafenib—kidney cancer	0.000274	0.00158	CcSEcCtD
Tolmetin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000273	0.00158	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00027	0.00156	CcSEcCtD
Tolmetin—Headache—Sorafenib—kidney cancer	0.00027	0.00156	CcSEcCtD
Tolmetin—Diarrhoea—Dactinomycin—kidney cancer	0.000269	0.00155	CcSEcCtD
Tolmetin—Gastritis—Doxorubicin—kidney cancer	0.000265	0.00153	CcSEcCtD
Tolmetin—Vomiting—Sunitinib—kidney cancer	0.000264	0.00152	CcSEcCtD
Tolmetin—Body temperature increased—Gemcitabine—kidney cancer	0.000263	0.00152	CcSEcCtD
Tolmetin—Headache—Sunitinib—kidney cancer	0.00026	0.0015	CcSEcCtD
Tolmetin—Nausea—Sorafenib—kidney cancer	0.000256	0.00148	CcSEcCtD
Tolmetin—Asthenia—Vincristine—kidney cancer	0.000252	0.00145	CcSEcCtD
Tolmetin—Vomiting—Dactinomycin—kidney cancer	0.00025	0.00144	CcSEcCtD
Tolmetin—Somnolence—Paclitaxel—kidney cancer	0.000248	0.00143	CcSEcCtD
Tolmetin—Nausea—Sunitinib—kidney cancer	0.000246	0.00142	CcSEcCtD
Tolmetin—Dyspepsia—Paclitaxel—kidney cancer	0.000245	0.00142	CcSEcCtD
Tolmetin—Dysuria—Doxorubicin—kidney cancer	0.000242	0.0014	CcSEcCtD
Tolmetin—Diarrhoea—Vincristine—kidney cancer	0.00024	0.00139	CcSEcCtD
Tolmetin—Asthenia—Gemcitabine—kidney cancer	0.000239	0.00138	CcSEcCtD
Tolmetin—Chest pain—Capecitabine—kidney cancer	0.000239	0.00138	CcSEcCtD
Tolmetin—Constipation—Paclitaxel—kidney cancer	0.000238	0.00138	CcSEcCtD
Tolmetin—Weight increased—Doxorubicin—kidney cancer	0.000236	0.00136	CcSEcCtD
Tolmetin—Weight decreased—Doxorubicin—kidney cancer	0.000235	0.00135	CcSEcCtD
Tolmetin—Nausea—Dactinomycin—kidney cancer	0.000233	0.00135	CcSEcCtD
Tolmetin—Dizziness—Vincristine—kidney cancer	0.000232	0.00134	CcSEcCtD
Tolmetin—Drowsiness—Doxorubicin—kidney cancer	0.000231	0.00134	CcSEcCtD
Tolmetin—Oedema—Capecitabine—kidney cancer	0.000229	0.00132	CcSEcCtD
Tolmetin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000228	0.00132	CcSEcCtD
Tolmetin—Diarrhoea—Gemcitabine—kidney cancer	0.000228	0.00132	CcSEcCtD
Tolmetin—Renal failure—Doxorubicin—kidney cancer	0.000227	0.00131	CcSEcCtD
Tolmetin—Stomatitis—Doxorubicin—kidney cancer	0.000225	0.0013	CcSEcCtD
Tolmetin—Urinary tract infection—Doxorubicin—kidney cancer	0.000225	0.0013	CcSEcCtD
Tolmetin—Thrombocytopenia—Capecitabine—kidney cancer	0.000224	0.00129	CcSEcCtD
Tolmetin—Vomiting—Vincristine—kidney cancer	0.000223	0.00129	CcSEcCtD
Tolmetin—Urticaria—Paclitaxel—kidney cancer	0.000221	0.00128	CcSEcCtD
Tolmetin—Haematuria—Doxorubicin—kidney cancer	0.00022	0.00127	CcSEcCtD
Tolmetin—Body temperature increased—Paclitaxel—kidney cancer	0.00022	0.00127	CcSEcCtD
Tolmetin—Abdominal pain—Paclitaxel—kidney cancer	0.00022	0.00127	CcSEcCtD
Tolmetin—Headache—Vincristine—kidney cancer	0.00022	0.00127	CcSEcCtD
Tolmetin—Epistaxis—Doxorubicin—kidney cancer	0.000218	0.00126	CcSEcCtD
Tolmetin—PTGS2—nephron—kidney cancer	0.000217	0.208	CbGeAlD
Tolmetin—Agranulocytosis—Doxorubicin—kidney cancer	0.000216	0.00125	CcSEcCtD
Tolmetin—Vomiting—Gemcitabine—kidney cancer	0.000212	0.00122	CcSEcCtD
Tolmetin—Headache—Gemcitabine—kidney cancer	0.000209	0.0012	CcSEcCtD
Tolmetin—Nausea—Vincristine—kidney cancer	0.000208	0.0012	CcSEcCtD
Tolmetin—Hepatitis—Doxorubicin—kidney cancer	0.000208	0.0012	CcSEcCtD
Tolmetin—Dyspepsia—Capecitabine—kidney cancer	0.000201	0.00116	CcSEcCtD
Tolmetin—Visual impairment—Doxorubicin—kidney cancer	0.0002	0.00115	CcSEcCtD
Tolmetin—Asthenia—Paclitaxel—kidney cancer	0.0002	0.00115	CcSEcCtD
Tolmetin—Nausea—Gemcitabine—kidney cancer	0.000198	0.00114	CcSEcCtD
Tolmetin—Erythema multiforme—Doxorubicin—kidney cancer	0.000196	0.00113	CcSEcCtD
Tolmetin—Constipation—Capecitabine—kidney cancer	0.000196	0.00113	CcSEcCtD
Tolmetin—Tinnitus—Doxorubicin—kidney cancer	0.000194	0.00112	CcSEcCtD
Tolmetin—Diarrhoea—Paclitaxel—kidney cancer	0.000191	0.0011	CcSEcCtD
Tolmetin—Indomethacin—PTGS2—kidney cancer	0.000189	0.0262	CrCbGaD
Tolmetin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000187	0.00108	CcSEcCtD
Tolmetin—Dizziness—Paclitaxel—kidney cancer	0.000184	0.00106	CcSEcCtD
Tolmetin—Urticaria—Capecitabine—kidney cancer	0.000182	0.00105	CcSEcCtD
Tolmetin—Abdominal pain—Capecitabine—kidney cancer	0.000181	0.00104	CcSEcCtD
Tolmetin—Body temperature increased—Capecitabine—kidney cancer	0.000181	0.00104	CcSEcCtD
Tolmetin—Flatulence—Doxorubicin—kidney cancer	0.000178	0.00103	CcSEcCtD
Tolmetin—Vomiting—Paclitaxel—kidney cancer	0.000177	0.00102	CcSEcCtD
Tolmetin—CXCL8—nephron tubule—kidney cancer	0.000176	0.169	CbGeAlD
Tolmetin—Aminohippurate—ABCB1—kidney cancer	0.000175	0.0242	CrCbGaD
Tolmetin—Headache—Paclitaxel—kidney cancer	0.000175	0.00101	CcSEcCtD
Tolmetin—Nausea—Paclitaxel—kidney cancer	0.000166	0.000956	CcSEcCtD
Tolmetin—Asthenia—Capecitabine—kidney cancer	0.000164	0.000948	CcSEcCtD
Tolmetin—Indomethacin—ABCB1—kidney cancer	0.000161	0.0222	CrCbGaD
Tolmetin—Diarrhoea—Capecitabine—kidney cancer	0.000157	0.000904	CcSEcCtD
Tolmetin—Chest pain—Doxorubicin—kidney cancer	0.000154	0.000888	CcSEcCtD
Tolmetin—Dizziness—Capecitabine—kidney cancer	0.000151	0.000874	CcSEcCtD
Tolmetin—Anaphylactic shock—Doxorubicin—kidney cancer	0.000147	0.000851	CcSEcCtD
Tolmetin—Oedema—Doxorubicin—kidney cancer	0.000147	0.000851	CcSEcCtD
Tolmetin—Vomiting—Capecitabine—kidney cancer	0.000145	0.00084	CcSEcCtD
Tolmetin—Thrombocytopenia—Doxorubicin—kidney cancer	0.000144	0.000834	CcSEcCtD
Tolmetin—Headache—Capecitabine—kidney cancer	0.000143	0.000828	CcSEcCtD
Tolmetin—SLC22A6—nephron tubule—kidney cancer	0.000138	0.132	CbGeAlD
Tolmetin—Nausea—Capecitabine—kidney cancer	0.000136	0.000785	CcSEcCtD
Tolmetin—Somnolence—Doxorubicin—kidney cancer	0.000131	0.000757	CcSEcCtD
Tolmetin—Dyspepsia—Doxorubicin—kidney cancer	0.00013	0.00075	CcSEcCtD
Tolmetin—Constipation—Doxorubicin—kidney cancer	0.000126	0.000728	CcSEcCtD
Tolmetin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000121	0.000696	CcSEcCtD
Tolmetin—SLC22A6—cortex of kidney—kidney cancer	0.000118	0.113	CbGeAlD
Tolmetin—Urticaria—Doxorubicin—kidney cancer	0.000117	0.000676	CcSEcCtD
Tolmetin—Abdominal pain—Doxorubicin—kidney cancer	0.000117	0.000673	CcSEcCtD
Tolmetin—Body temperature increased—Doxorubicin—kidney cancer	0.000117	0.000673	CcSEcCtD
Tolmetin—Asthenia—Doxorubicin—kidney cancer	0.000106	0.000611	CcSEcCtD
Tolmetin—Diarrhoea—Doxorubicin—kidney cancer	0.000101	0.000583	CcSEcCtD
Tolmetin—Dizziness—Doxorubicin—kidney cancer	9.75e-05	0.000563	CcSEcCtD
Tolmetin—MPO—renal system—kidney cancer	9.38e-05	0.0898	CbGeAlD
Tolmetin—Vomiting—Doxorubicin—kidney cancer	9.37e-05	0.000541	CcSEcCtD
Tolmetin—Headache—Doxorubicin—kidney cancer	9.24e-05	0.000533	CcSEcCtD
Tolmetin—MPO—kidney—kidney cancer	9.07e-05	0.0868	CbGeAlD
Tolmetin—CXCL8—Cellular Senescence—CDKN1B—kidney cancer	8.85e-05	0.000634	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—MAPK3—kidney cancer	8.79e-05	0.000629	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TP53—kidney cancer	8.79e-05	0.000629	CbGpPWpGaD
Tolmetin—Nausea—Doxorubicin—kidney cancer	8.76e-05	0.000506	CcSEcCtD
Tolmetin—CXCL8—Metabolism of proteins—PAX6—kidney cancer	8.75e-05	0.000626	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—CTSD—kidney cancer	8.71e-05	0.000623	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AKAP13—kidney cancer	8.65e-05	0.000619	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	8.62e-05	0.000617	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—VEGFA—kidney cancer	8.48e-05	0.000607	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GSTP1—kidney cancer	8.43e-05	0.000604	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—JUN—kidney cancer	8.43e-05	0.000603	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	8.39e-05	0.0006	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—MAPK1—kidney cancer	8.37e-05	0.000599	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDKN2A—kidney cancer	8.27e-05	0.000592	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ACY1—kidney cancer	8.12e-05	0.000581	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—ITPR2—kidney cancer	8.1e-05	0.00058	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—BCHE—kidney cancer	8.01e-05	0.000573	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TP53—kidney cancer	8.01e-05	0.000573	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ABCB1—kidney cancer	7.98e-05	0.000571	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CD4—kidney cancer	7.79e-05	0.000558	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GSTM1—kidney cancer	7.75e-05	0.000555	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	7.73e-05	0.000553	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—RELA—kidney cancer	7.67e-05	0.000549	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	7.56e-05	0.000541	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN2A—kidney cancer	7.56e-05	0.000541	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	7.5e-05	0.000537	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GPC3—kidney cancer	7.46e-05	0.000534	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CER1—kidney cancer	7.46e-05	0.000534	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—ITPR2—kidney cancer	7.36e-05	0.000527	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CYP1A1—kidney cancer	7.35e-05	0.000526	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDKN1B—kidney cancer	7.33e-05	0.000524	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	7.33e-05	0.000524	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—RELA—kidney cancer	7.27e-05	0.00052	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—PIK3CA—kidney cancer	7.26e-05	0.00052	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—MTOR—kidney cancer	7.13e-05	0.00051	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CCND1—kidney cancer	6.99e-05	0.0005	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—MAPK3—kidney cancer	6.97e-05	0.000499	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	6.93e-05	0.000496	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PDHB—kidney cancer	6.91e-05	0.000494	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—POMC—kidney cancer	6.89e-05	0.000493	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—ANXA1—kidney cancer	6.79e-05	0.000486	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN1B—kidney cancer	6.69e-05	0.000479	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—MAPK1—kidney cancer	6.63e-05	0.000474	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CCBL1—kidney cancer	6.49e-05	0.000465	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ACY1—kidney cancer	6.45e-05	0.000462	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—JUN—kidney cancer	6.37e-05	0.000456	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SFRP2—kidney cancer	6.34e-05	0.000454	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—IGF2—kidney cancer	6.2e-05	0.000444	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—ANXA1—kidney cancer	6.17e-05	0.000441	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CCBL1—kidney cancer	6.16e-05	0.000441	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.94e-05	0.000425	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—POMC—kidney cancer	5.89e-05	0.000421	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.87e-05	0.00042	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.73e-05	0.00041	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GLIPR1—kidney cancer	5.63e-05	0.000403	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPAT—kidney cancer	5.63e-05	0.000403	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—MYC—kidney cancer	5.61e-05	0.000401	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CDKN1B—kidney cancer	5.58e-05	0.0004	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AMER1—kidney cancer	5.57e-05	0.000398	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—VEGFA—kidney cancer	5.56e-05	0.000398	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TP53—kidney cancer	5.56e-05	0.000398	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.56e-05	0.000398	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.5e-05	0.000394	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PDHB—kidney cancer	5.48e-05	0.000392	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—POMC—kidney cancer	5.48e-05	0.000392	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL2—kidney cancer	5.46e-05	0.000391	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CCND1—kidney cancer	5.33e-05	0.000381	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	5.28e-05	0.000378	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—MAPK3—kidney cancer	5.26e-05	0.000377	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—APRT—kidney cancer	5.23e-05	0.000375	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—FH—kidney cancer	5.23e-05	0.000375	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—KRAS—kidney cancer	5.18e-05	0.000371	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CCBL1—kidney cancer	5.16e-05	0.000369	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	5.12e-05	0.000366	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CASP2—kidney cancer	5.11e-05	0.000366	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKAP13—kidney cancer	5.11e-05	0.000366	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—MAPK1—kidney cancer	5.01e-05	0.000359	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GPC3—kidney cancer	4.92e-05	0.000352	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CA2—kidney cancer	4.79e-05	0.000343	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GRB7—kidney cancer	4.68e-05	0.000335	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALAD—kidney cancer	4.67e-05	0.000334	CbGpPWpGaD
Tolmetin—PTGS2—Disease—GPC3—kidney cancer	4.67e-05	0.000334	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.66e-05	0.000334	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ST3GAL2—kidney cancer	4.55e-05	0.000326	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.53e-05	0.000324	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GLIPR1—kidney cancer	4.47e-05	0.00032	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPAT—kidney cancer	4.47e-05	0.00032	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALDH1A1—kidney cancer	4.45e-05	0.000319	CbGpPWpGaD
Tolmetin—PTGS1—renal system—kidney cancer	4.45e-05	0.0426	CbGeAlD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.41e-05	0.000316	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	4.39e-05	0.000314	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTGS2—kidney cancer	4.37e-05	0.000313	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.37e-05	0.000313	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ITPR2—kidney cancer	4.35e-05	0.000311	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ST3GAL2—kidney cancer	4.32e-05	0.000309	CbGpPWpGaD
Tolmetin—PTGS1—kidney—kidney cancer	4.3e-05	0.0412	CbGeAlD
Tolmetin—PTGS2—Spinal Cord Injury—MYC—kidney cancer	4.27e-05	0.000306	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PGK1—kidney cancer	4.27e-05	0.000305	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SLC5A3—kidney cancer	4.27e-05	0.000305	CbGpPWpGaD
Tolmetin—PTGS2—renal system—kidney cancer	4.25e-05	0.0407	CbGeAlD
Tolmetin—CXCL8—Cellular responses to stress—TP53—kidney cancer	4.2e-05	0.000301	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—LDHB—kidney cancer	4.18e-05	0.0003	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	4.18e-05	0.000299	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—FH—kidney cancer	4.16e-05	0.000297	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—APRT—kidney cancer	4.16e-05	0.000297	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	4.14e-05	0.000297	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—POMC—kidney cancer	4.14e-05	0.000296	CbGpPWpGaD
Tolmetin—PTGS2—kidney—kidney cancer	4.11e-05	0.0394	CbGeAlD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	4.1e-05	0.000293	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.06e-05	0.000291	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PGK1—kidney cancer	4.05e-05	0.00029	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SLC5A3—kidney cancer	4.05e-05	0.00029	CbGpPWpGaD
Tolmetin—PTGS1—cardiac atrium—kidney cancer	3.98e-05	0.0382	CbGeAlD
Tolmetin—PTGS2—Disease—SFRP2—kidney cancer	3.97e-05	0.000284	CbGpPWpGaD
Tolmetin—PTGS2—Disease—LDHB—kidney cancer	3.97e-05	0.000284	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CTNNA1—kidney cancer	3.94e-05	0.000282	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EIF4EBP1—kidney cancer	3.92e-05	0.00028	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HSPB1—kidney cancer	3.92e-05	0.00028	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GPC3—kidney cancer	3.91e-05	0.00028	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTEN—kidney cancer	3.81e-05	0.000273	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CA2—kidney cancer	3.8e-05	0.000272	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	3.8e-05	0.000272	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALAD—kidney cancer	3.7e-05	0.000265	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TCEB1—kidney cancer	3.7e-05	0.000265	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TCEB2—kidney cancer	3.7e-05	0.000265	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PSMD7—kidney cancer	3.64e-05	0.000261	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ANXA1—kidney cancer	3.64e-05	0.000261	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TSC1—kidney cancer	3.64e-05	0.000261	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CA9—kidney cancer	3.63e-05	0.00026	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	3.62e-05	0.000259	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ST3GAL2—kidney cancer	3.62e-05	0.000259	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	3.62e-05	0.000259	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	3.59e-05	0.000257	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.55e-05	0.000254	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALDH1A1—kidney cancer	3.53e-05	0.000253	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FLT1—kidney cancer	3.53e-05	0.000252	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—kidney cancer	3.51e-05	0.000251	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	3.5e-05	0.00025	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC5A3—kidney cancer	3.39e-05	0.000242	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PGK1—kidney cancer	3.39e-05	0.000242	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—POMC—kidney cancer	3.33e-05	0.000238	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—LDHB—kidney cancer	3.32e-05	0.000238	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PAK1—kidney cancer	3.27e-05	0.000234	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—JUNB—kidney cancer	3.27e-05	0.000234	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.16e-05	0.000226	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CRABP1—kidney cancer	3.09e-05	0.000221	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—POMC—kidney cancer	3.02e-05	0.000216	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RPL14—kidney cancer	3.01e-05	0.000215	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.99e-05	0.000214	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—CTNNB1—kidney cancer	2.95e-05	0.000212	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.91e-05	0.000208	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CA9—kidney cancer	2.88e-05	0.000206	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ITPR2—kidney cancer	2.87e-05	0.000205	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.84e-05	0.000203	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.82e-05	0.000202	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ITPR2—kidney cancer	2.72e-05	0.000195	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CA—kidney cancer	2.69e-05	0.000192	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.68e-05	0.000192	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IGF2—kidney cancer	2.67e-05	0.000191	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN2B—kidney cancer	2.66e-05	0.000191	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.64e-05	0.000189	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ACHE—kidney cancer	2.62e-05	0.000187	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTT1—kidney cancer	2.62e-05	0.000187	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IGF1R—kidney cancer	2.58e-05	0.000185	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	2.56e-05	0.000183	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—RAF1—kidney cancer	2.49e-05	0.000178	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SCARB1—kidney cancer	2.48e-05	0.000177	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.47e-05	0.000177	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2—kidney cancer	2.46e-05	0.000176	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CRABP1—kidney cancer	2.45e-05	0.000175	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PSMD7—kidney cancer	2.4e-05	0.000172	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.39e-05	0.000171	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—BCHE—kidney cancer	2.28e-05	0.000163	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PSMD7—kidney cancer	2.28e-05	0.000163	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ITPR2—kidney cancer	2.28e-05	0.000163	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SLC5A5—kidney cancer	2.25e-05	0.000161	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2—kidney cancer	2.23e-05	0.00016	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SLC2A1—kidney cancer	2.17e-05	0.000156	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HIF1A—kidney cancer	2.13e-05	0.000152	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TSC2—kidney cancer	2.12e-05	0.000152	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.11e-05	0.000151	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.1e-05	0.00015	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ACHE—kidney cancer	2.08e-05	0.000149	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTT1—kidney cancer	2.08e-05	0.000149	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SLC2A1—kidney cancer	2.06e-05	0.000147	CbGpPWpGaD
Tolmetin—PTGS2—Disease—JUNB—kidney cancer	2.05e-05	0.000146	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KDR—kidney cancer	2.03e-05	0.000146	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SCARB1—kidney cancer	1.97e-05	0.000141	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PTGS1—kidney cancer	1.95e-05	0.000139	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PSMD7—kidney cancer	1.91e-05	0.000137	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KIT—kidney cancer	1.87e-05	0.000134	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APC—kidney cancer	1.87e-05	0.000134	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.84e-05	0.000132	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTP1—kidney cancer	1.81e-05	0.00013	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—BCHE—kidney cancer	1.81e-05	0.000129	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—MAPK3—kidney cancer	1.8e-05	0.000129	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC5A5—kidney cancer	1.79e-05	0.000128	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—POMC—kidney cancer	1.78e-05	0.000128	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—BRAF—kidney cancer	1.76e-05	0.000126	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC2A1—kidney cancer	1.73e-05	0.000124	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ABCB1—kidney cancer	1.72e-05	0.000123	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—MAPK1—kidney cancer	1.71e-05	0.000122	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTM1—kidney cancer	1.67e-05	0.000119	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN2B—kidney cancer	1.66e-05	0.000119	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CA—kidney cancer	1.63e-05	0.000117	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—KRAS—kidney cancer	1.61e-05	0.000115	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP1A1—kidney cancer	1.58e-05	0.000113	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CA—kidney cancer	1.48e-05	0.000106	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RAF1—kidney cancer	1.47e-05	0.000105	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RELA—kidney cancer	1.46e-05	0.000105	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.46e-05	0.000105	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ERBB2—kidney cancer	1.46e-05	0.000104	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTP1—kidney cancer	1.44e-05	0.000103	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MTOR—kidney cancer	1.44e-05	0.000103	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ABCB1—kidney cancer	1.36e-05	9.75e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN1B—kidney cancer	1.35e-05	9.65e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HIF1A—kidney cancer	1.33e-05	9.53e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TSC2—kidney cancer	1.33e-05	9.5e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTM1—kidney cancer	1.32e-05	9.47e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2—kidney cancer	1.32e-05	9.44e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.3e-05	9.29e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCND1—kidney cancer	1.29e-05	9.2e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—JUN—kidney cancer	1.28e-05	9.19e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CTNNB1—kidney cancer	1.27e-05	9.12e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP1A1—kidney cancer	1.25e-05	8.97e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTEN—kidney cancer	1.24e-05	8.88e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—POMC—kidney cancer	1.18e-05	8.43e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APC—kidney cancer	1.17e-05	8.39e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—KIT—kidney cancer	1.17e-05	8.39e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VEGFA—kidney cancer	1.12e-05	8.02e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—BRAF—kidney cancer	1.1e-05	7.89e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK3—kidney cancer	1.06e-05	7.59e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MYC—kidney cancer	1.03e-05	7.38e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.03e-05	7.37e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK1—kidney cancer	1.01e-05	7.22e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KRAS—kidney cancer	9.53e-06	6.82e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTGS2—kidney cancer	9.39e-06	6.72e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—POMC—kidney cancer	9.35e-06	6.69e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RAF1—kidney cancer	9.2e-06	6.59e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ERBB2—kidney cancer	9.11e-06	6.52e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MTOR—kidney cancer	8.99e-06	6.43e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD4—kidney cancer	8.97e-06	6.42e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CA—kidney cancer	8.76e-06	6.27e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—kidney cancer	8.47e-06	6.06e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN1B—kidney cancer	8.43e-06	6.04e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTEN—kidney cancer	8.19e-06	5.86e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CTNNB1—kidney cancer	7.97e-06	5.7e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PTEN—kidney cancer	7.76e-06	5.56e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MAPK3—kidney cancer	6.63e-06	4.75e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PTEN—kidney cancer	6.5e-06	4.65e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MYC—kidney cancer	6.45e-06	4.62e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MAPK1—kidney cancer	6.31e-06	4.52e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—KRAS—kidney cancer	5.96e-06	4.27e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CA—kidney cancer	5.78e-06	4.14e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CA—kidney cancer	5.48e-06	3.92e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CA—kidney cancer	4.59e-06	3.28e-05	CbGpPWpGaD
